Centric Software positioned as a Leader and Ace Performer in the 2025 SPARK Matrix(TM): Product Lifecycle Management (PLM) for Process Industries by QKS Group

Pune, India, Sept. 08, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading Product Lifecycle Management (PLM) for Process Industries' vendors. Centric Software, with its comprehensive technology and customer experience management, has received strong ratings across the parameters of technology excellence and customer impact. QKS Group announced […]

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

(NASDAQ:SINT), Significant Development in the Estimated $30 Billion Global Infection-Prevention Market SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance (PTOL-85) for its patent application titled, “Antipathogenic Fibrous

Sonoco to Sell Temperature-Assured Packaging Business to Arsenal Capital Partners

(NYSE:SON), ThermoSafe Sale Completes Company's Transformation into a Global Metal and Fiber Packaging Leader Net Proceeds to be Used to Reduce Debt HARTSVILLE, S.C., Sept. 08, 2025 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced it has signed a definitive agreement to

GXO Leaders Receive 2025 Women in Supply Chain Award

(NYSE:GXO), Carmen Gil and Joanne Mawditt honored for their contributions to GXO's global success GREENWICH, Conn., Sept. 08, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world's largest pure-play contract logistics provider, announced today that Carmen Gil and Joanne Mawditt are recipients of the 2025 Women in Supply Chain award by Supply &

Beamr to Demonstrate Live 4K Quality Enhancement with NVIDIA Holoscan for Media

(NASDAQ:BMR), The high-efficiency solution for broadcasters of live events, enabling to reduce CDN costs by up to 50%, will be presented at IBC 2025 in Amsterdam, the Netherlands Herzliya, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced it will demonstrate real-time,

Talisker Resources Announces First Gold Sale from the Bralorne Gold Project

(TSX:TSK),(OTC US:TSKFF),(Other OTC:TSKFF),(TSX:TSK-WT), TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company“) (TSX: TSK, OTCQX: TSKFF) is pleased to announce the successful completion of its first gold sale from its 100% owned Bralorne Gold Project in British Columbia (“Bralorne”). The Company sold 707 ounces of gold in August, generating gross

InvestigateTV+ Returns to Weekdays for Third Season, Delivering Solutions-Oriented Journalism

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) — InvestigateTV+, Gray Media's national investigative program, is set to premiere its third season on Monday, September 8th, bringing viewers a fresh slate of episodes uncovering critical issues and providing tangible solutions. InvestigateTV+ airs weekdays in all 113 Gray markets and has expanded its reach into numerous non-Gray

Canterra Minerals Reports Highest Ever Gold Samples up to 535 g/t Au and Expands Mineralization at Wilding Gold Project, Newfoundland

(TSX-V:CTM),(OTC US:CTMCF),(Other OTC:CTMCF),(Frankfurt:DXZB), VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) — Canterra Minerals Corporation (TSXV: CTM) (OTCQB: CTMCF) (FSE: DXZB) (“Canterra” or the “Company”) is pleased to announce significant prospecting results from its Wilding Gold Project, in Central Newfoundland, including exceptional grades of 535 g/t Au. The Wilding Gold Project covers 55 km of

Ocular Therapeutix(TM) to Host Investor Day on September 30, 2025

(NasdaqGM:OCUL), Company to highlight ongoing AXPAXLI(TM) wet AMD registrational program, strategy and next steps in NPDR and DME, and global commercial opportunity for AXPAXLI Event to feature global retinal disease experts Dr. Arshad M. Khanani MD, MA, FASRS; Professor Adnan Tufail, MBBS, MD, FRCOphth; Dr. Eleonora Lad, MD, PhD; and Dr. Patricio G. Schlottmann, MD

Dianthus Therapeutics Announces Positive Data for Claseprubart (DNTH103) from the Phase 2 MaGic Trial in Generalized Myasthenia Gravis, Supporting Its Potential Best-In-Class Profile

(NASDAQ:DNTH), Claseprubart 300mg and 600mg Q2W doses both achieved statistically significant and clinically meaningful improvements in Myasthenia Gravis Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores at Week 13 Claseprubart demonstrated a rapid and sustained onset of action, with both doses achieving statistically significant improvements in MG-ADL and QMG scores at Week

Scroll to Top